BELLARMINE UNIVERSITY, LOUISVILLE, KY Electronic Cigarettes and Smoking Cessation Sarah Boone, Carolyn Little, Clay Owens, Jeremy Randolph, Genny Tibbs.

Slides:



Advertisements
Similar presentations
Jean-François ETTER Evelyne LASZLO Jean-Pierre ZELLWEGER Charles PERROT Thomas PERNEGER University of Geneva, Switzerland Smoking reduction with NRT: a.
Advertisements

Understanding and changing professional practice: the use of behaviour change technique methodology Susan Michie and Robert West Professors of Health Psychology,
The Novice User’s Experience of the Titan 510 Electronic Cigarette: a Mixed Methods Approach Victoria Lawson, Sharon Cahill & Lynne Dawkins School of Psychology,
E-cigarette use in England: Latest trends from the Smoking Toolkit Study Dr Jamie Brown University College London Dr Emma Beard, Dr Daniel Kotz, Prof Susan.
A Virtual Arm to Stop Smoking A comparative study B. Girard 1, V. Turcotte 1 and S. Bouchard 2 1.GRAP, Occupational psychology clinic Saguenay (Québec)
Effectiveness Of Nurse-clinician Led Smoking Cessation Clinic In Singapore Effectiveness Of Nurse-clinician Led Smoking Cessation Clinic In Singapore PRABHAKARAN.
ABCs of Behavioral Support Jonathan Foulds PhD. Penn State – College of Medicine
First vs. Second Generation E- Cigarettes: Predictors of choice and effects on tobacco craving and withdrawal symptoms Dr. Lynne Dawkins Drugs and Addictive.
Vaping profiles and preferences: an online survey of electronic cigarette users Dawkins, L., Turner, J. Roberts, A. & Soar, K. Drugs & Addictive Behaviours.
Prevalence of e-cigarette use and associations between e-cigarette use and cigarette cessation attempts and abstinence among Kansas adults Trevor Christensen,
Nicotine Replacement Therapy: Administration and Overview Barbara Hart, MPA and Claudia Lechuga, MS Bronx BREATHES T: (718) E:
Prevention strategies
Smoking Cessation. Opportunity for Physicians 70 percent of smokers want to quit. Without assistance only 5 percent are able to quit. Most try to quit.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2013.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2015.
1 CTRI Webinar: Combination Medication Effectiveness June 9, 2010 Stevens S. Smith, Ph.D. Megan E. Piper, Ph.D. Center for Tobacco Research & Intervention.
Unit 21 More on Smoking
Marques Gomes & Nabhani-Gebara | June 2014 Electronic cigarettes: Community Pharmacists’ Perception Ana Marques Gomes Mpharm, MRPharmS Shereen Nabhani.
Smoking Cessation for Pregnancy and Beyond: Virtual Clinic Companion Slides Catherine A. Powers, EdD, LSW PACE – Tobacco Prevention and Cessation Education.
Electronic cigarettes (e-cigarettes) are battery operated devices that resemble the appearance of a cigarette and produce a warm vapor when withdrawn from.
BEAUTI f UL: morBidity-mortality EvAlUaTion of the I f inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction Purpose.
Does Transdermal Nicotine-Induced Withdrawal Suppression Depend on Smokers’ Gender? Sarah E. Evans, Ph.D. Seminars in Addiction Psychiatry October 6, 2005.
Fatima Chaudhry. Why this drug was developed According to the Centers for Disease Control and Prevention (CDC), an estimated 45 million adults in the.
Journal Club Sidharth Bagga MD. Cytisus laborium L. (Golden rain acacia)
Real-world effectiveness of nicotine replacement therapy in pregnancy Leonie S. Brose, PhD Andy McEwen, PhD & Robert West, PhD University College London.
Clinical trial 2. Objective To evaluate efficacy and safety of varenicline for smoking cessation compared with sustained-release bupropion (bupropion.
Introduction Clopidogrel is metabolized by P450 (CYP)-isoenzymes: CYP 3A4/5, 1A2, 2B6, 2C9, and 2C19 1 Wide response variability and nonresponsiveness.
Norwich Medical School Faculty of Medicine and Health Science Longer-Term Smoking Abstinence after treatment by specialist or non-specialist advisors:
Can undergoing an internet based ACT intervention change the impact of predictors thought to lead to Substance Use? Leonidou. G., Savvides. S., N. & Karekla.
Effect of Depression on Smoking Cessation Outcomes Sonne SC 1, Nunes EV 2, Jiang H 2, Gan W 2, Tyson C 1, Reid MS 3 1 Medical University of South Carolina,
JOURNAL List 5 reasons why you think some teens start to use tobacco.
CCTN September 6 th, Recent Scientific Publications from the Clinical Trials Network David Liu, M.D. (CTN-0029) Harold Perl, Ph.D. (CTN-0015) Paul.
Agresti/Franklin Statistics, 1 of 56  Section 4.3 What Are Good Ways and Poor Ways to Experiment?
® Introduction Changes in Opioid Use for Chronic Low Back Pain: One-Year Followup Roy X. Luo, Tamara Armstrong, PsyD, Sandra K. Burge, PhD The University.
SMOKING AND ESTABLISHED CARDIOVASCULAR DISEASE: THE VARIABLE HABITS OF A PRIMARY CARE COHORT Dr Mairead Corrigan 1 PhD BSSc, Dr Margaret E Cupples 1 MD.
TOBACCO USE & OLDER SMOKERS. OLDER SMOKERS In 2004, 3.7 million people aged 65 and older were smokers and 16% of all people aged 50 and older smoked;
The COMBINE Study: Design and Methodology Stephanie S. O’Malley, Ph.D. for The COMBINE Study Research Group JAMA Vol. 295, , 2006 (May 3 rd.
Doctors In Turkey Smoke More SAHIN EM, OZER C, DAGDEVIREN N, AKTURK Z Trakya University Faculty of Medicine Department of Family Practice.
Clinical trial 2. Objective To evaluate efficacy and safety of varenicline for smoking cessation compared with sustained-release bupropion (bupropion.
Effects of a combination of varenicline and nicotine patch on post-quitting urges to smoke Katie Myers Smith BSc MSc CPsychol Research Fellow Wolfson Institute.
FDA Regulation of Tobacco Washington, DC October 21, 2015 What is Relative Risk-a look at the Continuum of Harm Aruni Bhatnagar, PhD, Professor, University.
Ten Years of Pharmacotherapy Trials in the CTN: An Overview.
Latest trends on smoking in England from the Smoking Toolkit Study Robert West Jamie Brown Last updated: 17th June 2013
Short-term efficacy of nicotine replacement therapy (NRT) for smoking cessation among adolescents and the role of compliance Charlotte Scherphof* Regina.
Efficacy of Combination First Line Agents for Smoking Cessation Sneha Baxi, Pharm.D. Pharmacy Practice Resident University of Illinois at Chicago.
-Tobacco is the leading preventable cause of disease, disability, and death in the United States (NIDA, 2012). -About 1 in every 5 deaths in the U.S. result.
Trends in electronic cigarette use in England Robert West Emma Beard Jamie Brown University College London
1 Smoking quiz Robert West University College London Rio de Janeiro 2006.
1 Varenicline for smoking cessation Robert West University College London Logroño, October
Electronic cigarette use for quitting smoking in England: 2015 Robert West Jamie Brown University College London
1 Behaviour change in theory and in real life Robert West University College London Stockholm, April 2008.
1 Recent studies of clinical significance University College London June 2011 Robert West.
E-Cigarettes: What’s the Real Medical Innovation Breakthrough? Dr Sudhanshu Patwardhan, MBBS, MS, MBA Senior International Engagement Manager, Nicoventures.
Acute exercise effects on craving and withdrawal symptoms among women attempting to quit smoking using nicotine replacement therapy Dr. Therese Harper.
Latest trends on smoking in England from the Smoking Toolkit Study Robert West Jamie Brown Last updated: 20th May 2016
What is the most we can achieve with behavioural support for smoking cessation? Robert West University College 1.
Hot topics in smoking cessation Robert West University College robertjwest 1.
1 Effects on smoking cessation of a national strategy to maximise NRT usage: the UK experience Robert West University College London WCTOH July 2006 Washington.
Key findings from scoping review
Smoking Cessation Medication
6 myths and facts about tobacco use disorder in people with mental health and substance use disorders Associate Professor.
Alcohol, Other Drugs, and Health: Current Evidence July–August 2017
Meta-analysis of Effectiveness of First-Line Smoking Cessation Pharmacotherapies 6 Months After Quitting Medication Estimated OR (95% CI) Est. abstinence.
Jonathan Foulds, Jessica M. Yingst, Susan Veldheer, Shari Hrabovsky,
Robert West University College London London March 2008
ABCs of Behavioral Support
Alcohol, Other Drugs, and Health: Current Evidence May-June, 2018
Personalized prevention: mobile application for smokers
Alcohol, Other Drugs, and Health: Current Evidence March–April 2018
Caring for the smoking asthmatic patient
Presentation transcript:

BELLARMINE UNIVERSITY, LOUISVILLE, KY Electronic Cigarettes and Smoking Cessation Sarah Boone, Carolyn Little, Clay Owens, Jeremy Randolph, Genny Tibbs

BELLARMINE UNIVERSITY, LOUISVILLE, KY Objectives Analyze Smoking in Kentucky List Methods of Smoking Cessation Acute Effects of Electronic Cigarettes Review the Evidence of Related Studies Compare Use of Electronic Cigarettes and Nicotine Patches

BELLARMINE UNIVERSITY, LOUISVILLE, KY Smoking in KY /states/kentucky/

BELLARMINE UNIVERSITY, LOUISVILLE, KY Smoking in KY

BELLARMINE UNIVERSITY, LOUISVILLE, KY Smoking in KY /states/kentuckyhttp:// 2010/states/kentucky/

BELLARMINE UNIVERSITY, LOUISVILLE, KY Smoking Cessation 80% of smokers who attempt cessation relapse within in first month of quitting 3-5% remain abstinent at 6 months (Polosa, BMC Public Health, 2011) Common Methods: –Electronic cigarettes –Nicotine Patches –Oral Medication –“Cold Turkey”

BELLARMINE UNIVERSITY, LOUISVILLE, KY Electronic Cigarettes Westenberger, FDA, 2009 P: Smokers I: Electronic Cigarettes C: Nicotine Patches O: Smoking Cessation

BELLARMINE UNIVERSITY, LOUISVILLE, KY Acute Effects of E-Cigarettes Vansickel, American Association for Cancer Research, 2010

BELLARMINE UNIVERSITY, LOUISVILLE, KY Acute Effects of E-Cigarettes 32 tobacco cigarette smokers Four products: – Own brand cigarette, “NPRO” electronic cigarettes, “Hydro” electronic cigarettes, or sham Outcome Measures: –Heart rate, plasma nicotine content, Tiffany Drobes Questionnaire of Smoking Urges Brief Vansickel, American Association for Cancer Research, 2010

BELLARMINE UNIVERSITY, LOUISVILLE, KY Acute Effects of E-Cigarettes Results: –Own brand increased plasma nicotine, CO concentration and heart rate –NPRO EC, Hydro EC, and sham smoking did not –Both EC exposed users to no nicotine or CO –Both EC didn’t increase heart rate –Both EC increased subjective ratings of acceptability Vansickel, American Association for Cancer Research, 2010

BELLARMINE UNIVERSITY, LOUISVILLE, KY Acute Effects of E-Cigarettes Conclusion: –Neither electronic cigarettes exposed users to measurable levels of nicotine or CO –Both suppressed nicotine/tobacco abstinence symptom ratings Vansickel, American Association for Cancer Research, 2010

BELLARMINE UNIVERSITY, LOUISVILLE, KY Electronic Cigarettes & Smoking Cessation Polosa, BMC Public Health, 2011

BELLARMINE UNIVERSITY, LOUISVILLE, KY Electronic Cigarettes & Smoking Cessation Methods: –5 visits: baseline and four follow up visits at week 4, 8, 12, and 24 –Baseline Measurements: Demographics and detailed smoking history Level of carbon monoxide in exhaled breath (eCO) –4 week supply of 7.4 mg nicotine cartridges given –Max use of 4 cartridges/day Polosa, BMC Public Health, 2011

BELLARMINE UNIVERSITY, LOUISVILLE, KY Electronic Cigarettes & Smoking Cessation ReducersHeavy ReducersQuittersSmoking Failure 50% reduction in number of cig/day compared to baseline 80% reduction in number of cig/day compared to baseline Smoking abstinence at 24 weeks < 50% reduction in number of cig/day compared to baseline Polosa, BMC Public Health, 2011

BELLARMINE UNIVERSITY, LOUISVILLE, KY Electronic Cigarettes & Smoking Cessation Results: –50% reduction shown in 13/40 subjects –Combined sustained 50% reduction and smoking abstinence in 22/40 (p≤0.001) Conclusions: –Reduction in cigarette smoking with e-cigarettes may increase motivation to quit –Gradual reductions in cigarette smoking can increase cessation Polosa, BMC Public Health, 2011

BELLARMINE UNIVERSITY, LOUISVILLE, KY Case Series on Smoking Cessation Utilizing E-cigs Caponnetto, Journal of Medical Case Reports, 2011

BELLARMINE UNIVERSITY, LOUISVILLE, KY Case Series on Smoking Cessation Utilizing E-cigs Three chronic smokers (two male, one female) Severe dependence to nicotine –Fagerstrom Test of Nicotine Dependence (FTND) –Exhaled Breath Carbon Monoxide Concentration (eCO) Previous cessation efforts (patches & group counseling) Caponnetto, Journal of Medical Case Reports, 2011.

BELLARMINE UNIVERSITY, LOUISVILLE, KY Case Series on Smoking Cessation Utilizing E-cigs Results: –Cessation status following the usage of E-cigs No relapse 6 months following study –Reduction in eCO –Variation in E-cig composition Regulation? Limitation – Small sample size Caponnetto, Journal of Medical Case Reports, 2011.

BELLARMINE UNIVERSITY, LOUISVILLE, KY Comparison: Nicotine Patch Therapy Myung et al. 2007, Am J Health-Syst Pharm

BELLARMINE UNIVERSITY, LOUISVILLE, KY Comparison: Nicotine Patch Therapy Study: –Meta-analysis of studies investigating efficacy of nicotine patches vs. placebo. Purpose: –Assess current literature –Determine an odds ratio for smoking cessation Myung et al. 2007, Am J Health-Syst Pharm

BELLARMINE UNIVERSITY, LOUISVILLE, KY Comparison: Nicotine Patch Therapy Methods: –16 RCT’s –Total subjects: 9,457 6,084 nicotine group 3,373 placebo group Results of Meta-analysis: Pooled OR (odds ratio) for 16 studies was shtml Myung et al. 2007, Am J Health-Syst Pharm

BELLARMINE UNIVERSITY, LOUISVILLE, KY Electronic Cigarettes for Smoking Cessation Bullen, Nat Inst Health Innov, 2013

BELLARMINE UNIVERSITY, LOUISVILLE, KY Electronic Cigarettes for Smoking Cessation: A Randomized Controlled Trial Purpose: –To assess whether E-cigarettes containing nicotine were more effective for smoking cessation than nicotine patches Methods: –657 subjects were selected for the study –Randomized by computerized block randomization –4:4:1 ratio Bullen, Nat Inst Health Innov, 2013

BELLARMINE UNIVERSITY, LOUISVILLE, KY Electronic Cigarettes for Smoking Cessation: A Randomized Controlled Trial Procedures: –Subjects used respective smoking cessation products for 12 weeks before a specific “quitting day” –The primary outcome measured was smoking abstinence six months after “quitting day” –Verified by self-report and carbon monoxide measurement Bullen, Nat Inst Health Innov, 2013

BELLARMINE UNIVERSITY, LOUISVILLE, KY Electronic Cigarettes for Smoking Cessation: A Randomized Controlled Trial Results: –Abstinence rates after six months Nicotine E-cigarette 7.3% Nicotine Patches5.8% Placebo E-cigarette4.1% –Study was underpowered due to low abstinence rates and could not conclude if E-cigarettes were superior to nicotine patches or placebo Bullen, Nat Inst Health Innov, 2013

BELLARMINE UNIVERSITY, LOUISVILLE, KY Summary Smoking Cessation Electronic Cigarettes Levels of nicotine or eCO were reduced Suppressed nicotine/tobacco abstinence symptom ratings Highest rates of abstinence after six months Greater success rates with “rituals” of smoking Nicotine Patch Odds ratio for sustained abstinence after 1 year: 1.79 (compared to placebo) Lowest rates of abstinence after six months

BELLARMINE UNIVERSITY, LOUISVILLE, KY Additional Resources Stop Smoking Classes Louisville – sses.htmhttp:// sses.htm Norton Healthcare Smoking Cessation Program – Kentucky Cabinet for Health & Family Services –

BELLARMINE UNIVERSITY, LOUISVILLE, KY References Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, Walker N. Electronic cigarettes for smoking cessation: a randomised controlled trial. Nat Inst Health Innov. 2013; 13:1-9. Caponnetto P, Polosa R, Russo C, Leotta C, Campagna D. Successful smoking cessation with electronic cigarettes in smokers with a documented history of recurring relapses: a case series. Journal of Medical Case Reports. 2011; 5: 585. Myung SK, Yoo KY, Oh SW, et al. Meta-analysis of studies investigating one-year effectiveness of trasdermal nicotine patches for smoking cessation. Am J Health-Syst Pharm.2007; 64: Polosa R, Caponnetto P, Morjaria JB, Papale G, Campagna D, Russo C. Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health. 2011; 11: doi: / Vansickel AR, Cobb CO, Weaver MF, Eissenberg TE. A clinical laboratory model for evaluating the acute effects of electronic “cigarettes”: nicotine delivery profile and cardiovascular and subjective effects. Amer Assoc Cancer Res. 2010; 19: